The high expression of IL-6 in the present study seems to suggest a close association with tumor aggressiveness, and blocking the cancer-associated inflammatory factor IL-6 alone or in combination with conventional anticancer therapies to inhibit its associated signaling may be a potential therapeutic strategy for the treatment of cancers in which IL-6 is the dominant signal. Here, IL6 is linked to neoplasm.